APEIRON INVESTMENT GROUP LTD. purchased 0.1% of their position (2.20K shares) of SENSEI BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.5K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 2/27/2023ACC: 0000921895-23-000615
10% Owner
Since Jul 2022
+2.20K
Net shares
Net buyer
$3.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.20K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.10K
Price / share
$1.61
Trade value
$1.78K
% of position
0.0%
2/23/2023
2.48M→2.48M
Common Stock
Indirect
Shares
+1.10K
Price / share
$1.60
Trade value
$1.76K
% of position
0.0%
2/23/2023
2.48M→2.49M
Total
Net shares
+2.20K
Net value
$3.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/23/2023 | P · Purchase | +1.10K | $1.61 | $1.78K | 0.0% | 2.48M | 2.48M |
| Common Stock Indirect | 2/23/2023 | P · Purchase | +1.10K | $1.60 | $1.76K | 0.0% | 2.48M | 2.49M |
| Total | +2.20K | $3.54K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned955.74K
Total
955.74K indirect955.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 955.74K | Indirect |
| Total | 955.74K | 955.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported